Kyorin Holdings Overview

  • Founded
  • 1923
  • Status
  • Public
  • Employees
  • 2,243
  • Stock Symbol
  • 4569
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $13.21
  • (As of Tuesday Closing)

Kyorin Holdings General Information


Kyorin Holdings, Inc. is a Japanese company which is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Media and Information Services (B2B)
Medical Supplies
Stock Exchange
Primary Office
  • 4-6 Kanda Surugadai
  • Chiyoda-ku
  • Tokyo, 101-8311
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kyorin Holdings Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.21 $13.05 $13.02 - $17.33 $757M 57.3M 76.1K $0.65

Kyorin Holdings Financials Summary

In Thousands,
TTM 31-Dec-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 791,075 892,516 1,059,776 1,026,437
Revenue 962,228 970,431 1,011,501 1,024,775
EBITDA 112,873 105,976 111,217
Net Income 37,418 57,809 56,552 61,954
Total Assets 1,469,580 1,514,980 1,583,743 1,560,559
Total Debt 184,112 198,358 218,306 216,650
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kyorin Holdings Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kyorin Holdings‘s full profile, request access.

Request a free trial

Kyorin Holdings Executive Team (2)

Name Title Board Seat Contact Info
Tomiharu Matsumoto Senior Managing Director
You’re viewing 1 of 2 executive team members. Get the full list »

Kyorin Holdings Board Members (4)

Name Representing Role Since
00000000 00000000000 Kyorin Holdings Board Member 000 0000
0000000 00000 Kyorin Holdings Board Member 000 0000
000000 000000 Kyorin Holdings Chairman & Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Kyorin Holdings Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kyorin Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kyorin Holdings‘s full profile, request access.

Request a free trial

Kyorin Holdings Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 01-Feb-2019 00000 0000 00.000 Other Equipment
MSD (Shiga Plant in Koka, Shiga Prefecture) 01-Oct-2012 Corporate Asset Purchase Buildings and Property 00000000
To view Kyorin Holdings’s complete investments history, request access »